Inhibrx Biosciences, Inc. INBX Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares?
- Inhibrx Biosciences, Inc. (INBX) reported convertible preferred stock authorized shares of 15M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares changed year-over-year?
- Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 15M to 15M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 15M to 15M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.